Delivery Order SPE2DR25D3103-SPE2DR26F9J85
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,275.15 to AmerisourceBergen Drug Corp for Estradiol-Norethindrone 0.5-0.1 mg tablets (28-count unit dose packaging). This is a firm fixed price, non-set-aside contract awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a $1,404.76 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol-Norethindrone 0.5-0.1 mg tablets (28-count units), with an ultimate completion date of April 23, 2025. This is a firm fixed-price, non-set-aside contract executed on April 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,602.53 to AmerisourceBergen Drug Corp for Estradiol 10 MCG Vaginal Insert (18-unit package) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.0375 mg in a quantity of 8 units under a firm fixed-price contract valued at $2,351.60. The award was made on November 20, 2025, with an ultimate completion date of December 18, 2025. This delivery order represents a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $3,192.88 to AmerisourceBergen Drug Corp for the supply of Estradiol 10 mcg vaginal inserts (8-count packages) under a firm fixed-price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $16,401.61 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol 10 mcg vaginal inserts (8-count package) on December 3, 2025, with completion scheduled for December 4, 2025. This non-competitive, firm fixed-price delivery order was issued under a competitive procurement process and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a $2,628.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Estradiol 10 MCG Vaginal Insert (8 count) on August 7, 2025, with completion scheduled for August 8, 2025. This delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $459 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 28 tablets of estradiol-norethindrone 1-0.5 mg. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. No subcontractors or additional context were provided regarding the delivery order. The single delivery order was awarded on July 26,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,184.36 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.05 mg patches (2 per week, 8-count units). The contract was competitively awarded without set-aside designation and is scheduled for completion by December 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J85Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,362.90 to AmerisourceBergen Drug Corp for the supply of Estradiol-Norethindrone 0.5-0.1 mg tablets in a quantity of 28 tablets, with an ultimate completion date of November 28, 2025. This non-competitive, firm fixed price delivery order was issued on November 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a primary supplier for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The delivery order represents a routine pharmaceutical procurement for hormone replacement therapy supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/25/25 |